Based in the United States, Avail Bio is a startup.
Avail Bio develops next-generation DNA synthesis technology using enzymes to accelerate synthetic biology and biomanufacturing processes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.